Loring Wolcott & Coolidge Fiduciary Advisors LLP MA Lowers Stock Position in Amgen Inc. $AMGN

Loring Wolcott & Coolidge Fiduciary Advisors LLP MA has reduced its stake in Amgen Inc. by 9.4%, selling 5,429 shares but still holding 52,030 shares valued at $18.28 million. Meanwhile, several other institutional investors increased their positions in Amgen. The article also highlights Amgen’s recent strong quarterly earnings, dividend declaration, and mixed analyst sentiment, with a consensus “Hold” rating and an average price target of $356.62.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin